The Wnt pathway plays a crucial role in self-renewal and differentiation of cells in the adult gut. In the present study, we revealed the functional consequences of inhibition of canonical Wnt signaling in the intestinal epithelium. The study was based on generation of a novel transgenic mouse strain enabling inducible expression of an N-terminally truncated variant of nuclear Wnt effector T cell factor 4 (TCF4). The TCF4 variant acting as a dominant negative (dn) version of wild-type (wt) TCF4 protein decreased transcription of β-catenin-TCF4-responsive genes. Interestingly, suppression of Wnt/β-catenin signaling affected asymmetric division of intestinal stem cells (ISCs) rather than proliferation. ISCs expressing the transgene underwent several rounds of division but lost their clonogenic potential and migrated out of the crypt. Expression profiling of crypt cells revealed that besides ISC-specific markers, the dnTCF4 production downregulated expression levels of epithelial genes produced in other crypt cells including markers of Paneth cells. Additionally, in Apc conditional knockout mice, dnTCF activation efficiently suppressed growth of Apc-deficient tumors. In summary, the generated mouse strain represents a convenient tool to study cell-autonomous inhibition of β-catenin-Tcf-mediated transcription.

Department of Cell and Developmental Biology Institute of Molecular Genetics Academy of Sciences of the Czech Republic Videnska 1083 Prague 4 Czech Republic

Division BIOCEV Institute of Molecular Genetics Academy of Sciences of the Czech Republic Videnska 1083 Prague 4 Czech Republic

Institute of Experimental Medicine Department of Cellular Neurophysiology Academy of Sciences of the Czech Republic Videnska 1083 Prague 4 Czech Republic

Laboratory of Haematooncology Institute of Molecular Genetics Academy of Sciences of the Czech Republic Videnska 1083 Prague Czech Republic

Zobrazit více v PubMed

Angus‐Hill ML, Elbert KM, Hidalgo J, Capecchi MR. 2011. T‐cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci USA 108:4914–4919. PubMed PMC

Asfaha S, Hayakawa Y, Muley A, Stokes S, Graham TA, Ericksen RE, Westphalen CB, von Burstin J, Mastracci TL, Worthley DL, Guha C, Quante M, Rustgi AK, Wang TC. 2015. Krt19(+)/Lgr5(‐) cells are radioresistant cancer‐initiating stem cells in the colon and intestine. Cell Stem Cell 16:627–638. PubMed PMC

Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, Bresolin S, Frasson C, Basso G, Guzzardo V, Fassina A, Cordenonsi M, Piccolo S. 2014. YAP/TAZ incorporation in the beta‐catenin destruction complex orchestrates the Wnt response. Cell 158:157–170. PubMed

Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato S, Cordenonsi M, Piccolo S. 2012. Role of TAZ as mediator of Wnt signaling. Cell 151:1443–1456. PubMed

Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H. 2009. Crypt stem cells as the cells‐of‐origin of intestinal cancer. Nature 457:608–611. PubMed

Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003–1007. PubMed

Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H. 2002. Beta‐catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251–263. PubMed

Buczacki SJ, Zecchini HI, Nicholson AM, Russell R, Vermeulen L, Kemp R, Winton DJ. 2013. Intestinal label‐retaining cells are secretory precursors expressing Lgr5. Nature 495:65–69. PubMed

Cai J, Maitra A, Anders RA, Taketo MM, Pan D. 2015. beta‐Catenin destruction complex‐independent regulation of Hippo‐YAP signaling by APC in intestinal tumorigenesis. Genes Dev 29:1493–1506. PubMed PMC

CancerGenomeAtlasNetwork. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337. PubMed PMC

Clevers H, Nusse R. 2012. Wnt/beta‐catenin signaling and disease. Cell 149:1192–1205. PubMed

de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ, Kioussis D. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 33:314–325. PubMed

Doubravska L, Krausova M, Gradl D, Vojtechova M, Tumova L, Lukas J, Valenta T, Pospichalova V, Fafilek B, Plachy J, Sebesta O, Korinek V. 2011. Fatty acid modification of Wnt1 and Wnt3a at serine is prerequisite for lipidation at cysteine and is essential for Wnt signalling. Cell Signal 23:837–848. PubMed

el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, Louvard D, Chambon P, Metzger D, Robine S. 2004. Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium. Genesis 39:186–193. PubMed

Fafilek B, Krausova M, Vojtechova M, Pospichalova V, Tumova L, Sloncova E, Huranova M, Stancikova J, Hlavata A, Svec J, Sedlacek R, Luksan O, Oliverius M, Voska L, Jirsa M, Paces J, Kolar M, Krivjanska M, Klimesova K, Tlaskalova‐Hogenova H, Korinek V. 2013. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells. Gastroenterology 144:381–391. PubMed

Fevr T, Robine S, Louvard D, Huelsken J. 2007. Wnt/beta‐catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 27:7551–7559. PubMed PMC

Garabedian EM, Roberts LJ, McNevin MS, Gordon JI. 1997. Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice. J Biol Chem 272:23729–23740. PubMed

Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally‐controlled site‐specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen‐inducible Cre‐ER(T) and Cre‐ER(T2) recombinases. Nucleic Acids Res 27:4324–4327. PubMed PMC

Ireland H, Kemp R, Houghton C, Howard L, Clarke AR, Sansom OJ, Winton DJ. 2004. Inducible Cre‐mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta‐catenin. Gastroenterology 126:1236–1246. PubMed

Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. 1998. Depletion of epithelial stem‐cell compartments in the small intestine of mice lacking Tcf‐4. Nat Genet 19:379–383. PubMed

Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a beta‐catenin‐Tcf complex in APC‐/‐ colon carcinoma. Science 275:1784–1787. PubMed

Krausova M, Korinek V. 2014. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26:570–579. PubMed

Kuhnert F, Davis CR, Wang HT, Chu P, Lee M, Yuan J, Nusse R, Kuo CJ. 2004. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf‐1. Proc Natl Acad Sci USA 101:266–271. PubMed PMC

Kuraguchi M, Wang XP, Bronson RT, Rothenberg R, Ohene‐Baah NY, Lund JJ, Kucherlapati M, Maas RL, Kucherlapati R. 2006. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet 2:e146. PubMed PMC

Lukas J, Mazna P, Valenta T, Doubravska L, Pospichalova V, Vojtechova M, Fafilek B, Ivanek R, Plachy J, Novak J, Korinek V. 2009. Dazap2 modulates transcription driven by the Wnt effector TCF‐4. Nucleic Acids Res 37:3007–3020. PubMed PMC

Nagy A, Rossant J, Nagy R, Abramow‐Newerly W, Roder JC. 1993. Derivation of completely cell culture‐derived mice from early‐passage embryonic stem cells. Proc Natl Acad Sci USA 90:8424–8428. PubMed PMC

Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, Meng Z, Lin KC, Yu FX, Alexander CM, Wang CY, Guan KL. 2015. Alternative Wnt Signaling Activates YAP/TAZ. Cell 162:780–794. PubMed PMC

Pinto D, Gregorieff A, Begthel H, Clevers H. 2003. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 17:1709–1713. PubMed PMC

Pospichalova V, Tureckova J, Fafilek B, Vojtechova M, Krausova M, Lukas J, Sloncova E, Takacova S, Divoky V, Leprince D, Plachy J, Korinek V. 2011. Generation of two modified mouse alleles of the Hic1 tumor suppressor gene. Genesis 49:142–151. PubMed

Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ. 2012. The Pan‐ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149:146–158. PubMed PMC

Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, Stewart AF, Dymecki SM. 2000. High‐efficiency deleter mice show that FLPe is an alternative to Cre‐loxP. Nat Genet 25:139–140. PubMed

Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC. 2012. beta‐Catenin‐driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151:1457–1473. PubMed PMC

Roth S, Franken P, Sacchetti A, Kremer A, Anderson K, Sansom O, Fodde R. 2012. Paneth cells in intestinal homeostasis and tissue injury. PLoS One 7:e38965. PubMed PMC

Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, Batlle E, Simon‐Assmann P, Clevers H, Nathke IS, Clarke AR, Winton DJ. 2004. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18:1385–1390. PubMed PMC

Schuijers J, Junker JP, Mokry M, Hatzis P, Koo BK, Sasselli V, van der Flier LG, Cuppen E, van Oudenaarden A, Clevers H. 2015. Ascl2 acts as an R‐spondin/Wnt‐responsive switch to control stemness in intestinal crypts. Cell Stem Cell 16:158–170. PubMed

Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70–71. PubMed

Stancikova J, Krausova M, Kolar M, Fafilek B, Svec J, Sedlacek R, Neroldova M, Dobes J, Horazna M, Janeckova L, Vojtechova M, Oliverius M, Jirsa M, Korinek V. 2015. NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling. Cell Signal 27:245–256. PubMed

Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD, de Sauvage FJ. 2011. A reserve stem cell population in small intestine renders Lgr5‐positive cells dispensable. Nature 478:255–259. PubMed PMC

Tumova L, Pombinho AR, Vojtechova M, Stancikova J, Gradl D, Krausova M, Sloncova E, Horazna M, Kriz V, Machonova O, Jindrich J, Zdrahal Z, Bartunek P, Korinek V. 2014. Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Mol Cancer Ther 13:812–822. PubMed

Valenta T, Hausmann G, Basler K. 2012. The many faces and functions of beta‐catenin. Embo J 31:2714–2736. PubMed PMC

van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon‐Pon‐Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H. 2002. The beta‐catenin/TCF‐4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250. PubMed

van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange DE, Begthel H, van den Born M, Guryev V, Oving I, van Es JH, Barker N, Peters PJ, van de Wetering M, Clevers H. 2009. Transcription factor achaete scute‐like 2 controls intestinal stem cell fate. Cell 136:903–912. PubMed

van Es JH, Haegebarth A, Kujala P, Itzkovitz S, Koo BK, Boj SF, Korving J, van den Born M, van Oudenaarden A, Robine S, Clevers H. 2012a. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self‐renewal. Mol Cell Biol. 32:1918–1927. PubMed PMC

van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, Thiele A, van den Born M, Begthel H, Brabletz T, Taketo MM, Clevers H. 2005. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7:381–386. PubMed

van Es JH, Sato T, van de Wetering M, Lyubimova A, Nee AN, Gregorieff A, Sasaki N, Zeinstra L, van den Born M, Korving J, Martens AC, Barker N, van Oudenaarden A, Clevers H. 2012b. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol 14:1099–1104. PubMed PMC

Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. 2007. Restoration of p53 function leads to tumour regression in vivo. Nature 445:661–665. PubMed

Waaler J, Machon O, Tumova L, Dinh H, Korinek V, Wilson SR, Paulsen JE, Pedersen NM, Eide TJ, Machonova O, Gradl D, Voronkov A, von Kries JP, Krauss S. 2012. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Res 72:2822–2832. PubMed

Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR 3rd, Nusse R. 2003. Wnt proteins are lipid‐modified and can act as stem cell growth factors. Nature 423:448–452. PubMed

Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T. 2007. Loss of beta‐catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528–541. PubMed PMC

Differential requirements for Smarca5 expression during hematopoietic stem cell commitment

Wnt/β-Catenin Signaling Promotes Differentiation of Ischemia-Activated Adult Neural Stem/Progenitor Cells to Neuronal Precursors

β-Catenin-TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation

Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells